Jurkat T-cell leukemia cells, for instance, are made refractory to Fas-mediated apoptosis by their expression of CD44v6 and v9 isoforms [24], and CD44v7 in rat adenocarcinoma cells confers apoptosis resistance by tumor cell-matrix cross-talk [25]. This evidence concerns the gene FAS and T-cell leukemia.